最新文献：
Forastiere, A. A. and B. A. Burtness (2007). "Epidermal growth factor receptor inhibition in head and neck cancer--more insights, but more questions." J Clin Oncol 25(16): 2152-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17538157
Temam, S., H. Kawaguchi, et al. (2007). "Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer." J Clin Oncol 25(16): 2164-70.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17538160
Agulnik, M., G. da Cunha Santos, et al. (2007). "Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib." J Clin Oncol 25(16): 2184-90.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17538163
最新文献：
Forastiere, A. A. and B. A. Burtness (2007). "Epidermal growth factor receptor inhibition in head and neck cancer--more insights, but more questions." J Clin Oncol 25(16): 2152-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17538157
Temam, S., H. Kawaguchi, et al. (2007). "Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer." J Clin Oncol 25(16): 2164-70.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17538160
Agulnik, M., G. da Cunha Santos, et al. (2007). "Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib." J Clin Oncol 25(16): 2184-90.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17538163
